Healthcare
Health Management International’s profit crashes 38% to $1.6m
Health Management International’s profit crashes 38% to $1.6m
Deferred tax assets pulled earnings down.
Here’s why Raffles Medical Group is heavily dependent on its overseas businesses
Local competition heats up as Singapore boosts public healthcare.
Singapore’s silver tsunami: Elder care spending to skyrocket to $49b per year by 2030
It’s almost ten times the city-state’s current spending.
Who will be among SBR's inaugural list of most influential people in health and fitness aged 40 and under?
Nominations are accepted until September 8.
Raffles Med’s net profit jumps by 4.5% to $16.7m
On back of higher patient load, clinic network expansion.
Here’s the chink in the armor of supposedly sturdy healthcare stocks
Expansion to overseas markets aren’t risk-free.
The doctor is online: Singaporeans prefer virtual physician check-ups over face-to-face consultations
3 in 4 said they would prefer self-directed healthcare.
Here’s what’s holding IHH Healthcare back in its aggressive overseas expansion
Skyrocketing staff costs aren’t letting up.
Chart of the day: Check out how Singapore’s medical devices market is facing a surplus bubble
Trade liberalisation is causing supply to skyrocket, analysts say.
Singapore’s public hospitals may struggle to provide sufficient capacity for patients by 2030
Hospital admissions will skyrocket to 791,000 yearly.
Chart of the Day: Healthcare expenditure to triple by 2030 as silver tsunami bites
Singapore will spend $44b for healthcare in less than two decades.
Will aggressive overseas expansion backfire for local healthcare companies?
Returns will suffer due to huge capex needs.
Here’s why Raffles Med isn’t fazed by intensifying local healthcare competition
It has extensive presence overseas.
Pioneer Generation to get $190m in Medisave top-ups this year
Top-ups range from $200 to $800.
Here’s why Raffles Med has no problem securing top medical talent in China
They rely on their group practice model.
Q&M Dental Group’s third-largest China deal could open larger opportunities, analysts say
It will buy stakes in a dental research firm for SGD13.8m.
Can IHH Healthcare withstand rising cost pressure?
Staff costs have skyrocketed to unprecedented levels.
Read Here
Advertise
Sign Up
Commentary
Singapore’s family offices: Time to professionalise or risk falling behind
Liquidity crucial to stock market reform